Dexrazoxane, a chelating agent, has been approved for use in combination with anthracyclines to reduce the risk of cardiotoxicity
Approved for long-term weight management in 2023 under the name Zepbound, its been shown to significantly lower A1C levels and body weight in clinical trials
References Ward, P
doi: 10.3390/jof6040305 67 SpiewskiT.KrzesiskiW.KauewiczA.PrasadR.ZaworskaA
IGF1 LR3s longer half-life makes it more suitable for systemic effects and sustained receptor start, while IGF-1 DESs shorter half-life may be advantageous for more localized or acute effects
Genital lentiginosis This disorder, also known as penile lentigo, penile lentiginosis, atypical penile lentigo, vulval lentigo, penile melanosis,and vulval melanosis, is discussed under pathology of the external genitalia